MedChemComm (in full: Medicinal Chemistry Communications) is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry, including drug discovery, pharmacology and pharmaceutical chemistry. Until December 2019, it was published monthly by the Royal Society of Chemistry in partnership with the European Federation for Medicinal Chemistry, of which it was the official journal. Authors can elect to have accepted articles published as open access.[1] According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.495, ranking it 27th out of 59 journals in the category "Chemistry, Medicinal"[2] and 163 out of 289 journals in the category "Biochemistry & Molecular Biology".[3]
The editor-in-chief is Mike Waring (Newcastle University).[4]
As of January 1, 2020 - the journal is now called RSC Medicinal Chemistry and continues to be published monthly under this new name.[5]
^"RSC Open Science". Royal Society of Chemistry. 2006-10-01. Retrieved 2012-07-07.
^"Journals Ranked by Impact: Chemistry, Medicinal". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.{{cite book}}: CS1 maint: postscript (link)(subscription required)
^"Journals Ranked by Impact: Biochemistry & Molecular Biology". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.{{cite book}}: CS1 maint: postscript (link)(subscription required)
^Editorial Board Retrieved on 2023-06-14.
^"A new name for MedChemComm". Royal Society of Chemistry. Retrieved 2020-10-15.
Chemistry portal Medicine portal MedChemComm (in full: Medicinal Chemistry Communications) is a peer-reviewed scientific journal publishing original (primary)...
ChemComm (or Chemical Communications), formerly known as Journal of the Chemical Society D: Chemical Communications (1969–1971), Journal of the Chemical...
PhysChemComm was a peer-reviewed scientific journal that was published by the Royal Society of Chemistry between 1998 and 2003. It covered all aspects...
properties on the binding kinetics of a ligand to its biological target". MedChemComm. 3 (4): 449–452. doi:10.1039/c2md00270a. ISSN 2040-2503. Flexner C (1998)...
strategies for the discovery of polyketides and nonribosomal peptides". MedChemComm. 3 (8): 932–937. doi:10.1039/C2MD20120H. ISSN 2040-2511. Pfeifer BA,...
the journal has a 2021 impact factor of 3.890. Natural Product Reports MedChemComm List of scientific journals List of scientific journals in chemistry...
Garneau-Tsodikova, Sylvie (23 April 2018). "What are the drugs of the future?". MedChemComm. 9 (5): 757–758. doi:10.1039/c8md90019a. ISSN 2040-2503. PMC 6072476...
cholinesterases with affinity to the muscarinic receptors M1 and M2". MedChemComm. 8 (6): 1346–1359. doi:10.1039/c7md00149e. PMC 6072511. PMID 30108847...
V, Beaumont K, Kalgutkar AS (2013). "Metabolism-guided drug design". MedChemComm. 4 (4): 631. doi:10.1039/C2MD20317K. Mellerup ET, Plenge P (July 1986)...
Index Index Medicus/MEDLINE/PubMed Scopus List of scientific journals in chemistry Journal of Materials Chemistry B MedChemComm "Biomaterials science editorial...
(1972–1996) (formerly J. Chem. Soc. A) Journal of the Chemical Society, Faraday Transactions (1972–1989) (formerly J. Chem. Soc. B) Journal of the Chemical...
Global Information
